Effects of Task-Based Mirror Therapy for Post-stroke Shoulder-Hand Syndrome (NCT07428811) | Clinical Trial Compass
RecruitingNot Applicable
Effects of Task-Based Mirror Therapy for Post-stroke Shoulder-Hand Syndrome
Pakistan34 participantsStarted 2025-11-05
Plain-language summary
The study aims to determine the effects of task-based mirror therapy on edema, pain and upper limb motor function with shoulder-hand syndrome in post stroke patients.
This randomized clinical trial will take place at Ittefaq Hospital and Trust Lahore and Alara healthcare clinic, Lahore involving 34 participants aged 45-75 years. Using a non-probability convenience sampling method, participants will be randomly assigned by online randomizing tool into two groups: experimental group (17 participants) and control group (17 participants). Both groups will undergo treatment for 30 minutes a day, five days a week, over four weeks. Each task will be performed by repeating each movement 20 times per set for three sets, with a 2-minute break between sets. There will also be 2-minute intervals between each completed task Outcome measures will include pain intensity assessed by the Numeric Pain Rating Scale (NPRS), edema measured by the figure-of-eight method, and upper limb motor function evaluated using the Functional Independence measure (FIM). Assessments will occur at baseline and post-intervention.
Who can participate
Age range
45 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria: Age 45 to 75 years.
* Both male and female patients are included in the study.
* Subacute stroke patients having stroke less than 6 months are included in this study.
* Stable participants having a stroke severity score \> 6 on National Institute of Health Stroke Scale (NIHSS).
* Modified Ashworth scale score ≤ 2 of the affected upper extremity.
* Montreal Cognitive Assessment (MoCA) score ≥ 24.
* Patients who can sit with or without support.
* No contractures of the affected shoulder, elbow, wrist and fingers.
* Participants who have no history of peripheral nerve injury or musculoskeletal disease
Exclusion Criteria:
* • Participants who have medical problems or co-morbidities that interdict their participation in the study.
* Patients with severe apraxia, somatosensory problems.
* Unilateral neglect
* Severe contractures of the affected shoulder, elbow, wrist and finger.
* Participants who show the symptoms of global or receptive aphasia.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.